Volume 137, Issue 5 , Pages 1071-1076, May 2009
Recovery of left ventricular function after surgical correction of mitral regurgitation caused by leaflet prolapse
Objective
Recovery of ventricular function after surgical correction of mitral regurgitation is often incomplete. We studied clinical and echocardiographic factors influencing return of normal left ventricular ejection fraction after mitral valve repair or replacement for mitral regurgitation caused by leaflet prolapse.
Methods
We evaluated 1063 patients who had mitral valve repair or replacement between January 1, 1980, and December 31, 2000. A total of 2488 echocardiograms with follow-up ejection fractions were available for analysis.
Results
Of the patients, 761 were men, 924 had valve repair, and 85% underwent surgery during the study's second decade. Compared with patients who had the operation in the 1980s, patients who had surgery in the 1990s had significantly smaller preoperative left heart dimensions and a 2.4-fold greater likelihood of an ejection fraction more than 60% during follow-up. Factors independently associated with higher ejection fraction at follow-up included valve repair (vs replacement), freedom from preoperative myocardial infarction, operation in the 1990s, greater preoperative ejection fraction, and smaller left ventricular dimensions. Patients with an ejection fraction of less than 50% at discharge were 3.5-fold less likely to recover normal ejection fraction during long-term follow-up (P < .001). Patients had a greater likelihood of a follow-up ejection fraction more than 60% if preoperative ejection fraction was more than 65% (hazard ratio, 1.7) or left ventricular end-systolic dimension was less than 36 mm (hazard ratio, 2.0).
Conclusion
Early repair of mitral regurgitation caused by leaflet prolapse, before deterioration in left heart size or function, increases the likelihood of subsequent normalization of left ventricular ejection fraction.
CTSNet classification: 17, 23, 35
Abbreviations and Acronyms: EF, ejection fraction, HR, hazard ratio, LV, left ventricular, LVEDD, left ventricular end-diastolic dimension, LVEF, left ventricular ejection fraction, LVESD, left ventricular end-systolic dimension, MR, mitral regurgitation, MV, mitral valve
To access this article, please choose from the options below
Conflicts of interest: Drs Suri, Schaff, Dearani, Daly, Mullany, and Orszulak have no conflicts of interest with this manuscript. Dr Sundt has stated consultant/advisory board: Boston Scientific Advisory Board. Dr Enriquez-Sarano has stated research grants: Edwards Lifesciences, AstraZeneca, and Pfizer; honoraria: Edwards Lifesciences; and consultant/advisory board: Edwards Lifesciences.
PII: S0022-5223(08)01748-0
doi:10.1016/j.jtcvs.2008.10.026
© 2009 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.
Volume 137, Issue 5 , Pages 1071-1076, May 2009
